Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03524469 · ClinicalTrials.gov registry record
Studying Infant Nutrition and Blood Sugar
A clinical trial, sponsored by University of Rochester.
- Completed
- Registry status
- 156
- Enrollment target
NCT03524469: Completed study, sponsored by University of Rochester.
NCT03524469 is a clinical trial that has completed, run by University of Rochester. The registered enrollment target is 156 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03524469 has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 156 participants
- Enrollment target
Study Summary
The purpose of this study is to learn about how breast milk from mothers with insulin-resistance may be different. Investigators are specifically studying insulin concentrations in breast milk. Investigators are also studying how insulin in breast milk might affect a baby's intestines and pancreas.
Primary Outcome
Postprandial urine (60-90 minute) will be tested for C peptide and creatinine and the ratio will be calculated.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2024-12-01 |
What the finished NCT03524469 record still lists
NCT03524469 is an observational study that tracks outcomes without assigning an intervention. The registered 156 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03524469 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03524469 about?
NCT03524469 is a clinical study titled "Studying Infant Nutrition and Blood Sugar". The purpose of this study is to learn about how breast milk from mothers with insulin-resistance may be different. Investigators are specifically studying insulin concentrations in breast milk. Investigators are also studying how insulin in breast milk might affect a baby's intestines and pancreas.
What is the current status of trial NCT03524469?
This trial is currently completed. The enrollment target is 156 participants. The study started on 2018-06-01. Estimated completion is 2024-12-01.
Who is sponsoring clinical trial NCT03524469?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03082755 · 156 participants · Phase 4
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
- NCT04047628 · 156 participants · Phase 3
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- NCT04166877 · 156 participants · Phase 4
Magnesium Infusion for Pain Management in Critically Ill Trauma Patients
- NCT04533464 · 156 participants · Phase 2
MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI